Patients' values for health states associated with hepatitis c and physicians' estimates of those values
The American Journal of GastroenterologyPublished 1 September 2001
Scott J. Cotler
Citations44
SJR quartileQ1
SJR score2.34
SNIP2.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Patients’ values for health states associated with hepatitis c and physicians’ estimates of those values are compared to determine which states should be considered to be hepatitis c-free.
Abstract
There was little agreement between patients' preference values about hepatitis C and their physicians' estimates of those values. Utility analysis could facilitate shared decision making about hepatitis C.
Keywords
MedicineEconomics, Econometrics and Finance
Annals of Internal MedicineMeasuring Health-Related Quality of Life
3,935 Citations1993Gordon Guyatt, David H. Feeny +1 more
Patients, clinicians, and health care administrators are all keenly interested in the effects of medical interventions on HRQL, because increasing efforts exist to incorporate HRQLs as measures of the quality of care and of clinical effectiveness, and because payers are beginning to use HRQL information in reimbursement decisions.
New England Journal of MedicineInterferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
3,500 Citations1998John G. McHutchison, Stuart C. Gordon +8 more
In patients with chronic hepatitis C, initial therapy withinterferon and ribavirin was more effective than treatment with interferon alone.
New England Journal of MedicineThe Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
3,024 Citations1999Miriam J. Alter, Deanna Kruszon-Moran +6 more
The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
The LancetNatural history of liver fibrosis progression in patients with chronic hepatitis C
3,023 Citations1997Thierry Poynard, Pierre Bédossa +1 more
The host factors of ageing, alcohol consumption, and male sex have a stronger association with fibrosis progression than virological factors in HCV infection.
The LancetRandomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
2,330 Citations1998Thierry Poynard, Patrick Marcellin +9 more
AnInterferon alpha2b plus ribavirin combination is more effective than 48 weeks of interferonalpha2b monotherapy and has an acceptable safety profile.
Journal of Health EconomicsMeasurement of health state utilities for economic appraisal
2,200 Citations1986George W. Torrance
A framework for economic appraisal is presented displaying the various components that must be measured, and showing how the three forms of analysis relate to the framework and to each other.
GastroenterologyMorbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
1,408 Citations1997Giovanna Fattovich, G. Giustina +20 more
In this cohort of patients, life expectancy is relatively long, in agreement with the morbidity data showing a slowly progressive disease.
New England Journal of MedicineInterferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
1,300 Citations1998Gary L. Davis, Rafael Esteban +9 more
In patients with chronic hepatitis C who relapse after treatment withinterferon, therapy with interferon and oral ribavirin results in higher rates of sustained virologic, biochemical, and histologic response than treatment withInterferon alone.
HepatologyInterrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
1,230 Citations1990Kendo Kiyosawa, Takeshi Sodeyama +9 more
The slow, sequential progression from acute hepatitis C virus—related non‐A, non‐B hepatitis through chronic hepatitis and cirrhosis to hepatocellular carcinoma is suggested to support a causal association between hepatitis Cirus and hepato Cell carcinoma.
New England Journal of MedicineClinical Outcomes after Transfusion-Associated Hepatitis C
1,215 Citations1995Myron J. Tong, Neveen S. El-Farra +2 more
In a group of patients seen at a referral center, chronic post-transfusion hepatitis C was a progressive disease and, in some patients, led to death from either liver failure or hepatocellular carcinoma.
Journal of Chronic DiseasesUtility approach to measuring health-related quality of life
1,072 Citations1987George W. Torrance
It is concluded that the utility approach is beyond the experimental stage, and is now a viable alternative for investigators to use in measuring health-related quality of life.
New England Journal of MedicineClinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
915 Citations1999Elizabeth Kenny-Walsh
Most of the women with HCV infection 17 years after receiving HCV-contaminated anti-D immune globulin had evidence of slight or moderate hepatic inflammation on liver biopsy, about half had fibrosis, and 2 percent had probable or definite cirrhosis.
HepatologyMeta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
678 Citations1996Thierry Poynard, Vincent Leroy +5 more
The best efficacy/risk ratio was in favor of 3 MU three times per week for at least 12 months in patients with chronic hepatitis C who had never been treated with interferon.
HepatologyThe Long–Term Pathological Evolution of Chronic Hepatitis C
583 Citations1996Michitami Yano, H. Kumada +8 more
The importance of grading and staging liver biopsy lesions in chronic hepatitis C, particularly for patients with high‐grade necroinflammation, septal fibrosis, and regions of modularity on initial biopsy who are at high risk of developing advanced cirrhosis in the ensuing decade is demonstrated.
HepatologyChronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
564 Citations1998Graham R. Foster, Robert Goldin +1 more
Patients with chronic HCV infection who had used intravenous drugs in the past had the greatest impairment in quality-of-life scores, but the reduction in quality of life scores was still found in patients who had never used drugs.
HepatologyReduction of Health–Related Quality of Life in Chronic Hepatitis C and Improvement With Interferon Therapy
401 Citations1999Herbert L. Bonkovsky, Michael J. Woolley
It is concluded that patients with chronic hepatitis C with or without cirrhosis have markedly reduced HRQOL, and successful interferon therapy provides meaningful improvements in HRZOL in patients with Chronic hepatitis C.
HepatologyHealth-related quality of life in chronic hepatitis C: Impact of disease and treatment response
330 Citations1999John E. Ware, Martha Bayliss +2 more
Successful treatment of CHC improved HQL as measured by both CHC‐specific and generic measures of functional health and well being, as well as changes in HQL among treatment responders.
Quality of Life ResearchA questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C
178 Citations1997Martha Bayliss, Barbara Gandek +4 more
A 69-item questionnaire measuring generic functioning and well-being and disease-specific health outcomes was developed and tested using the pre-treatment data from patients with chronic hepatitis C participating in two randomized trials of interferon α-2b, finding that CHC patients scored worse on the generic scales than patients with other chronic conditions and worse than a healthy general population.
Canadian Journal of OphthalmologyDifference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration
137 Citations2000Gary C. Brown, Melissa M. Brown +1 more
Patients' and ophthalmologists' perceptions of quality of life, as measured by utility analysis, associated with visual loss secondary to age-related macular degeneration (AMD) are evaluated.
Digestive Diseases and SciencesHealth assessment for chronic HCV infection
121 Citations1996Robert L. Carithers, David Sugano +1 more
Patients with chronic hepatitis C scored significantly lower than patients with hypertension in seven of the subscales and two additional generic scales in this survey, and were most comparable to those with type II diabetes.
Annals of Allergy Asthma & ImmunologyRelationship Between Quality of Life Instruments, Health State Utilities, and Willingness to Pay in Patients with Asthma
111 Citations1998Karen Blumenschein, Magnus Johannesson
The two quality of life instruments performed about equally well in terms of being correlated with and being able to explain the responses to the health state utility questions and the willingness to pay questions.
Journal of Viral HepatitisPretreatment symptoms and dosing regimen predict side‐effects of interferon therapy for hepatitis C
79 Citations2000Cotler, Wartelle +4 more
Patient characteristics, including pretreatment symptoms, gender and nationality, as well as daily IFN dosing are associated with the development of debilitating adverse effects on IFN therapy.
Journal of Cardiac FailurePatient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure
63 Citations1999Edward P. Havranek, Karen M. Mcgovern +4 more
Utility scores are valid measures of HRQL in patients with heart failure, and cost-effectiveness analyses of heart failure treatments incorporating utilities in the outcome measure can be meaningful.
PubMedA comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
48 Citations1997C. L. Bennett, Gretchen B. Chapman +5 more
Physicians and patients differ in their perspectives on expected quality of life with metastatic prostate cancer, and the need to assess patients' utilities directly is emphasized.
HepatologyImpaired Health–Related Quality of Life in Chronic Hepatitis C: the How, But Not the Why
46 Citations1999Raymond S. Koff
The SF-36 (short form-36) questionnaire is the principal generic tool used in reporting quality of life changes by managed care plans and the one most frequently used in clinical trials of a variety of interventions in a number of disorders.